AzTrials
AzTrials

Humeral FracturesNCT00358787

Management of Displaced Supracondylar Fractures of the Humerus Using Lateral vs. Crossed K-wires

A study testing Crossed K-wiring of supracondylar fracture of the humerus and Lateral K-wiring of supracondylar fracture of the humerus in people with Humeral Fractures, run by University of British Columbia at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Completely displaced (Type III) supracondylar fractures of the humerus are treated in the operating room and are held together with pins stuck into the bone. There are two ways of inserting the pins: crossed and laterally. Read more about this study

Who is it for?
Ages 3 to 7 years
Conditions the study is for
Humeral Fractures
What is being tested?
Crossed K-wiring of supracondylar fracture of the humerus and Lateral K-wiring of supracondylar fracture of the humerus
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteCanada
Study dates
Jul 2008to Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Male and female patients scheduled for closed reduction and K wiring of supracondylar fractures of the humerus under general anaesthesia a
  • Type-3 Supracondylar fractures of the humerus.
  • Aged 3 to 7 years old
  • Consent to participate in the study

Who cannot join

  • Open supracondylar fractures of the humerus
  • Children with pre-operative ulnar nerve injury
  • Supracondylar fractures with compartment syndrome needing fasciotomy
  • Supracondylar fractures needing vascular repair
  • Refusal to provide informed consent

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • British Columbia Children's Hospital

    Vancouver, British Columbia, V6H 3V4

Other trials in Canada

About this study

Official title: Management of Displaced Supracondylar Fractures of the Humerus Using Lateral Versus Cross K Wires: A Prospective Randomized Clinical Trial

Completely displaced (Type III) supracondylar fractures of the humerus are treated in the operating room and are held together with pins stuck into the bone. There are two ways of inserting the pins: crossed and laterally. The crossed method is often used because it is thought to be more stable, but this method also carries a risk of hitting the ulnar nerve. It is not known which method is more stable. Our hypothesis is that loss of reduction will be equivalent between the two pinning methods.

Read the detailed description

Children with type III supracondylar fractures of humerus who meet the study inclusion criteria will be invited to participate in the study by the on call orthopaedic surgeon. All patients will be required to provide informed consent. Patients will then be randomized through a random number software package and will commence immediately after confirmation of inclusion into the study. The fracture is reduced and fixed percutaneously either with crossed or lateral K wires, according to which group the subject was randomized to. Post reduction antero-posterior and lateral radiographs of the elbow are done in the operating room. Above elbow cast is applied. Radiographs are taken at follow-up visits to the clinic. The radiographs are measured to determine loss of reduction between immediate post-op films and films taken immediately prior to pin removal.

Being tested
Crossed K-wiring of supracondylar fracture of the humerus, Lateral K-wiring of supracondylar fracture of the humerus
Keywords
Supracondylar fracture, humerus, ulnar nerve injury, Baumann's angle, Supracondylar fracture of the humerus
Medical subject headings
Humeral Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Crossed K-wiring of supracondylar fracture of the humerusProcedure or surgery

    Closed reduction of the fracture followed by crossed K wire percutaneous pinning.

  • Lateral K-wiring of supracondylar fracture of the humerusProcedure or surgery

    Closed reduction of the fracture followed by lateral K wire percutaneous pinning.

Study groups in NCT00358787
Study groupRoleWhat they receive
1Active comparatorCrossed K wire orientation for surgical management of a type III Supracondylar fracture.
Receives: Procedure: Crossed K-wiring of supracondylar fracture of the humerus
2Active comparatorLateral K wire orientation for surgical management of a type III Supracondylar fracture.
Receives: Procedure: Lateral K-wiring of supracondylar fracture of the humerus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Loss of reduction between lateral K wires and crossed K wires in the treatment of supracondylar fractures of the humerus (at pin removal)

Secondary outcomes (2)
  1. Functional outcome (3 years post-op)

    Measured: 3 years

  2. Rate of iatrogenic ulnar nerve injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2006 (estimated)
  2. Study startJul 2008
  3. Primary completionNov 2017
  4. Study completionNov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00358787
Sponsor's protocol ID
H04-70532
Other IDs
W04-0180
Status last verified
Jan 2018
First submitted
28 Jul 2006
Last updated
10 Jan 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Crossed K-wiring of supracondylar fracture of the humerus and Lateral K-wiring of supracondylar fracture of the humerus in people with Humeral Fractures, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Loss of reduction between lateral K wires and crossed K wires in the treatment of supracondylar fractures of the humerus (at pin removal). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in